Drug formulation technologists are specialized experts who focus on the development and refinement of pharmaceutical products to ensure that drugs deliver their intended therapeutic effects safely and efficiently. Their responsibilities include designing formulations that balance drug stability, solubility, and bioavailability while maintaining patient compliance. They work with a range of dosage forms such as tablets, capsules, injectables, and topical applications, selecting appropriate excipients and optimizing processing parameters. By using advanced techniques and scientific knowledge, these technologists ensure that the final drug product meets rigorous quality standards and regulatory requirements.
Besides formulation development, drug formulation technologists are involved in scaling up processes from the laboratory to commercial manufacturing, ensuring reproducibility and cost-effectiveness. They conduct thorough evaluations, including stability testing, dissolution profiling, and compatibility assessments, to guarantee product performance throughout its shelf life. Collaboration with cross-functional teams—such as regulatory affairs, quality control, and production—is essential to address challenges and accelerate time-to-market. As the pharmaceutical landscape evolves with emerging technologies like controlled-release systems and nanocarriers, drug formulation technologists continue to play a pivotal role in advancing drug delivery science and improving patient outcomes worldwide. Their expertise is crucial in driving innovation and ensuring that new medicines reach patients safely and efficiently. Ultimately, their work helps transform scientific discoveries into practical treatments that improve global health.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico